Evidence map›Paper›PMID 34140338›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Lessons from a local effort to screen for SARS-CoV-2.

Noah J Silverstein, Jeremy Luban

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Noah J SilversteinProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.ORCID https://orcid.org/0000-0001-5688-9978
Jeremy LubanProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605; jeremy.luban@umassmed.edu.

Funding

The HUSH complex in HIV-1 latencyR37AI147868 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JEREMY LUBAN · 2019 to 2026
$6.4M
Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variantR01AI148784 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUBAN, JEREMY · 2020 to 2024
$4.1M
Mechanism of epigenetic inheritance in a mouse model of acute paternal stressF30HD100110 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERSTEIN, NOAH JACOB · 2019 to 2022
$135k
NIAID NIH HHS R01 AI148784NIAID NIH HHS R37 AI147868NICHD NIH HHS F30 HD100110
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asymptomatic InfectionsMass ScreeningViral LoadColoradoCOVID-19HumansSARS-CoV-2

Identifiers

PMID34140338
PMCPMC8255953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.